Cargando…

Treatment of Major Depressive Disorder in Patients Failing Initial Therapy: An Excel-Based Pharmacoeconomic Model

Detalles Bibliográficos
Autores principales:	Malone, Daniel C., Tierney, John G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2007
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437673/ http://dx.doi.org/10.18553/jmcp.2007.13.s6-a.1

Ejemplares similares

Pharmacoeconomics and Considerations for Injectable Products: Focus on Colony-Stimulating Factors
por: Chrischilles, Elizabeth A., et al.
Publicado: (2003)

Introduction to the Special Issue of PharmacoEconomics on Major Depressive Disorders
por: Greenberg, Paul E., et al.
Publicado: (2021)

Pharmacoeconomic Benefits of Antihypertensive Therapy
por: Gonzalez, Edgar R.
Publicado: (2007)

The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration
por: Ogrinc, G, et al.
Publicado: (2008)

Essentials of pharmacoeconomics
por: Rascati, Karen L.
Publicado: (2014)

Principles of pharmacoeconomics /
Publicado: (1996)

C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia
por: Mencacci, Claudio, et al.
Publicado: (2013)

Pharmacoeconomic considerations in the treatment of breast cancer
por: Pallis, Athanasios, et al.
Publicado: (2010)

Pharmacoeconomic evaluations in the treatment of actinic keratoses
por: Tolley, Keith, et al.
Publicado: (2017)

Pharmacoeconomic analysis of antibiotic therapy in maxillofacial surgery
por: Orzechowska-Wylęgała, Bogusława, et al.
Publicado: (2017)

Cough up for just a cup of coffee: Pharmacoeconomics of depression
por: Swaminath, G.
Publicado: (2008)

Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment
por: Kowalik, Krzysztof, et al.
Publicado: (2018)

Pharmacoeconomic evaluation of treatment effectiveness with selected biologic treatment in rheumatoid arthritis therapy
por: Kowalik, Krzysztof, et al.
Publicado: (2018)

Pharmacoeconomic aspects of the treatment of pituitary gland tumours
por: Sowiński, Jerzy, et al.
Publicado: (2013)

Systematic review of pharmacoeconomic models for schizophrenia
por: Zhou, Junwen, et al.
Publicado: (2018)

It's Only a Pharmacoeconomic Model--Believe It or Not
por: Fairman, Kathleen A., et al.
Publicado: (2008)

Knowledgeability and Identification: Explaining Military Interprofessional Healthcare Teams’ Excellence and Readiness
por: Stalmeijer, Renée E
Publicado: (2021)

The Shift Toward Evidence-Based Medicine - The Role of Community-Based Guidelines
por: Kleinke, J. D., et al.
Publicado: (2005)

Pharmacoeconomic evaluation of venlafaxine compared with citalopram in generalized anxiety disorder
por: ZHANG, JINGJING, et al.
Publicado: (2013)

Asthma: a major pediatric health issue
por: Smyth, Rosalind L
Publicado: (2002)

Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease
por: Rao, Vamshi K., et al.
Publicado: (2018)

Pharmacoeconomics in COPD: lessons for the future
por: Starkie, Helen J, et al.
Publicado: (2008)

Fluid management: the pharmacoeconomic dimension
por: Vincent, Jean-Louis
Publicado: (2000)

Drug Policy Research & Pharmacoeconomics
Publicado: (2008)

Development of pharmacoeconomics guidelines for India
por: Thomas, Dixon, et al.
Publicado: (2014)

Formulary Management Methods and Pharmacoeconomics
por: Curtiss, Frederic R.
Publicado: (2003)

Major Depressive Disorder Effects on Wound Healing in Peripheral Arterial Disease Patients Following Lower Extremity Amputation
por: Shan, Holly, et al.
Publicado: (2023)

A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine
por: Bhambri, Rahul, et al.
Publicado: (2015)

Management of NSAID-Associated Upper GI Disorders Using AMCP’s Framework for Quality Drug Therapy
por: Cryer, Byron, et al.
Publicado: (2005)

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)
por: Cross, Robert W, et al.
Publicado: (2018)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki, Akiko, et al.
Publicado: (2014)

Pharmacoeconomic Modeling of Drug Therapies for Multiple Sclerosis - Are We Building Houses on Sand?
por: Curtiss, Frederic R.
Publicado: (2007)

Grand Challenges in Pharmacoeconomics and Health Outcomes
por: Dubois, Dominique J.
Publicado: (2010)

Pharmacoeconomics guidelines: The need of hour for India
por: Oberoi, Sukhvinder Singh, et al.
Publicado: (2014)

Pharmacoeconomic studies in Nepal: the need of the hour
por: Acharya, Mahip
Publicado: (2014)

Pharmacoeconomics in Africa: needs, prospect and challenges
por: Ben-Ajepe, Temitope, et al.
Publicado: (2021)

CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021)

Pharmacoeconomic Challenges in the Management of Diabetic Nephropathy
por: Rodby, Roger A.
Publicado: (2004)

Pharmacoeconomic Evaluations: Guidelines for Drug Purchasers
por: Langley, Paul C., et al.
Publicado: (2020)

Haemophilia A: Pharmacoeconomic Review of Prophylaxis Treatment versus On-Demand
por: Unim, Brigid, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dpif0nchtra98ibd17isk9itd3